below the consensus of $944.8 million, and Q2 life sciences revenue of $127.9 million, weaker than the consensus of $130.7 million. KeyCorp (KEY) closed down more than -4% after Citigroup downgraded ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback